mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.03 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.04 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.05 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |